Merdury Biopharmaceutical Statistics

Total Valuation

TPEX:6932 has a market cap or net worth of TWD 3.43 billion. The enterprise value is 3.30 billion.

Market Cap	3.43B
Enterprise Value	3.30B

Important Dates

The next estimated earnings date is Thursday, May 14, 2026.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:6932 has 418.44 million shares outstanding. The number of shares has decreased by -0.29% in one year.

Current Share Class	418.44M
Shares Outstanding	418.44M
Shares Change (YoY)	-0.29%
Shares Change (QoQ)	-2.05%
Owned by Insiders (%)	42.69%
Owned by Institutions (%)	n/a
Float	215.66M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	15.60
P/TBV Ratio	16.00
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-49.13
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-57.22

Financial Position

The company has a current ratio of 8.84, with a Debt / Equity ratio of 0.18.

Current Ratio	8.84
Quick Ratio	8.33
Debt / Equity	0.18
Debt / EBITDA	n/a
Debt / FCF	-0.69
Interest Coverage	-76.33

Financial Efficiency

Return on equity (ROE) is -26.37% and return on invested capital (ROIC) is -14.35%.

Return on Equity (ROE)	-26.37%
Return on Assets (ROA)	-13.57%
Return on Invested Capital (ROIC)	-14.35%
Return on Capital Employed (ROCE)	-26.50%
Weighted Average Cost of Capital (WACC)	-4.59%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, TPEX:6932 has paid 61,000 in taxes.

Income Tax	61,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.91% in the last 52 weeks. The beta is -1.62, so TPEX:6932's price volatility has been lower than the market average.

Beta (5Y)	-1.62
52-Week Price Change	-35.91%
50-Day Moving Average	8.29
200-Day Moving Average	8.46
Relative Strength Index (RSI)	55.06
Average Volume (20 Days)	540,278

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-68.55M
Pretax Income	-67.17M
Net Income	-67.23M
EBITDA	-56.91M
EBIT	-68.55M
Earnings Per Share (EPS)	-0.16

Full Income Statement

Balance Sheet

The company has 163.77 million in cash and 39.67 million in debt, with a net cash position of 124.10 million or 0.30 per share.

Cash & Cash Equivalents	163.77M
Total Debt	39.67M
Net Cash	124.10M
Net Cash Per Share	0.30
Equity (Book Value)	219.67M
Book Value Per Share	0.52
Working Capital	154.99M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -50.84 million and capital expenditures -6.88 million, giving a free cash flow of -57.72 million.

Operating Cash Flow	-50.84M
Capital Expenditures	-6.88M
Depreciation & Amortization	11.64M
Net Borrowing	-4.16M
Free Cash Flow	-57.72M
FCF Per Share	-0.14

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPEX:6932 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.29%
Shareholder Yield	0.29%
Earnings Yield	-1.96%
FCF Yield	-1.68%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2